Moderna drops, Arbutus pops after patent ruling means vaccine maker could owe royalties on billions in COVID shot revenueBusiness Insider • 12/01/21
ABUS Stock Alert: The Moderna News That Has Arbutus Biopharma Shares Rocketing TodayInvestorPlace • 12/01/21
Preliminary Data Shows that Arbutus' Capsid Inhibitor, AB-836 is Generally Safe and Well-Tolerated and Provides Robust Antiviral ActivityGlobeNewsWire • 12/01/21
Arbutus Shares Are Soaring As Moderna Loses Appeal Of Board Ruling On COVID-19 Vaccine Delivery Technology PatentBenzinga • 12/01/21
Arbutus Biopharma: Recent Acquisition Of Dicerna Makes It An Attractive InvestmentSeeking Alpha • 11/20/21
Arbutus Announces New Data on AB-729 in Late Breaker Poster Presentation at AASLD - The Liver Meeting®GlobeNewsWire • 11/10/21
Arbutus Biopharma Corporation (ABUS) CEO Bill Collier on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/04/21
Arbutus Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/04/21
Arbutus Announces Late-Breaker Abstract Accepted for Presentation at AASLD - The Liver Meeting® 2021GlobeNewsWire • 11/01/21
Will Arbutus Biopharma (ABUS) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 10/28/21
Arbutus to Report Third Quarter 2021 Financial Results and Provide Corporate UpdateGlobeNewsWire • 10/21/21
Do Options Traders Know Something About Arbutus Biopharma (ABUS) Stock We Don't?Zacks Investment Research • 09/27/21